MG
Markel Group Portfolio holdings
AUM
$11.8B
This Quarter Return
+6.53%
1 Year Return
+20.14%
3 Year Return
+76.16%
5 Year Return
+141.94%
10 Year Return
+315.36%
AUM
$5.02B
AUM Growth
+$5.02B
(+7.1%)
Cap. Flow
+$55.9M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
42.57%
Holding
141
New
3
Increased
52
Reduced
1
Closed
2
Top Buys
| 1 |
Amazon
AMZN
|
$9.61M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$9.59M |
| 3 |
Goldman Sachs
GS
|
$5.22M |
| 4 |
Brookfield
BN
|
$3.1M |
| 5 |
Apollo Global Management
APO
|
$3.01M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$32.8M |
| 2 |
Core Laboratories
CLB
|
$11.1M |
| 3 |
NXP Semiconductors
NXPI
|
$3.83M |
Sector Composition
| 1 | Financials | 31.42% |
| 2 | Consumer Discretionary | 17.93% |
| 3 | Healthcare | 11.24% |
| 4 | Industrials | 11.22% |
| 5 | Consumer Staples | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Baxter International
BAX
$12.1B
| $1.38M | 0.03% |
22,000
| – | – |
|
127
W.R. Berkley
WRB
$27.4B
| $1.2M | 0.02% |
18,000
+10,000
| +125% | +$667K |
|
128
International Flavors & Fragrances
IFF
$16.8B
| $1.14M | 0.02% |
+8,000
| New | +$1.14M |
|
129
Atlanta Braves Holdings Series A
BATRA
$2.89B
| $1.08M | 0.02% |
42,600
| – | – |
|
130
Microchip Technology
MCHP
$34.2B
| $718K | 0.01% |
+8,000
| New | +$718K |
|
131
Goodyear
GT
$2.4B
| $665K | 0.01% |
+20,000
| New | +$665K |
|
132
Bristol-Myers Squibb
BMY
$96.7B
| $637K | 0.01% |
10,000
| – | – |
|
133
Hormel Foods
HRL
$13.9B
| $611K | 0.01% |
19,000
+12,000
| +171% | +$386K |
|
134
Booking.com
BKNG
$181B
| $366K | 0.01% |
200
| – | – |
|
135
Merck
MRK
$210B
| $359K | 0.01% |
5,600
| – | – |
|
136
Liberty Latin America Class A
LILA
$1.58B
| $350K | 0.01% |
14,720
| – | – |
|
137
HEICO
HEI
$44.4B
| $337K | 0.01% |
3,750
| – | – |
|
138
Novartis
NVS
$248B
| $318K | 0.01% |
3,700
| – | – |
|
139
Schlumberger
SLB
$52.2B
| $279K | 0.01% |
4,000
| – | – |
|
|
140
NXP Semiconductors
NXPI
$57.5B
| – | – |
-35,000
| Closed | -$3.83M |
|
|
141
Core Laboratories
CLB
$553M
| – | – |
-110,000
| Closed | -$11.1M |
|